Sort   by:  
 Page size 
UnknownDrosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361 | biostudies-literature
UnknownAssessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.
Not available
S-EPMC5777601 | biostudies-literature
UnknownNearly 70 years later: the continued unraveling of Castleman disease.
Not available
S-EPMC9827149 | biostudies-literature
UnknownGamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model.
Not available
S-EPMC9784560 | biostudies-literature
UnknownProfile of elotuzumab and its potential in the treatment of multiple myeloma.
Not available
S-EPMC4438995 | biostudies-literature
UnknownEpigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.
Not available
S-EPMC8699806 | biostudies-literature
UnknownTargeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.
Not available
S-EPMC10290473 | biostudies-literature
UnknownIdiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
Not available
S-EPMC8894931 | biostudies-literature
UnknownCharacterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.
Not available
S-EPMC3774816 | biostudies-literature
UnknownGlobal public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis.
Not available
S-EPMC9421978 | biostudies-literature
Sort   by:  
 Page size